Effects of SGLT-2 inhibitors for the patients with non-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.
Phase 4
Recruiting
- Conditions
- on-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.
- Registration Number
- JPRN-UMIN000018913
- Lead Sponsor
- Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of allergy to SGLT-2 inhibitors 2) HB/HC/autoimmune hepatitis 3) Pregnancy or lactation in women 4) Under insulin treatment 5) Excess alcohol consumption male; >/= 30g/day female; >/= 20g/day 6) Inadequacy for this therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method GGT
- Secondary Outcome Measures
Name Time Method HbA1c, Body weight, HOMA-IR